DNA methylation at DLGAP2 and risk for relapse in alcohol dependence during acamprosate treatment.

MLA

Özel, Fatih, et al. “DNA Methylation at DLGAP2 and Risk for Relapse in Alcohol Dependence during Acamprosate Treatment.” Drug & Alcohol Dependence, vol. 256, Mar. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.drugalcdep.2024.111116.

APA

Özel, F., Di Criscio, M., Lupu, D. I., Sarkisyan, D., Hlady, R. A., Robertson, K. D., Bakalkin, G., Liu, Y., Biernacka, J. M., Karpyak, V. M., Ekström, T. J., & Rüegg, J. (2024). DNA methylation at DLGAP2 and risk for relapse in alcohol dependence during acamprosate treatment. Drug & Alcohol Dependence, 256, N.PAG. https://doi.org/10.1016/j.drugalcdep.2024.111116

Chicago

Özel, Fatih, Michela Di Criscio, Diana Ioana Lupu, Daniil Sarkisyan, Ryan A. Hlady, Keith D. Robertson, Georgy Bakalkin, et al. 2024. “DNA Methylation at DLGAP2 and Risk for Relapse in Alcohol Dependence during Acamprosate Treatment.” Drug & Alcohol Dependence 256 (March): N.PAG. doi:10.1016/j.drugalcdep.2024.111116.